(Q80282718)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17486328%20AND%20SRC:MED&resulttype=core&format=json

30 December 2019

title

The influence of hepatic impairment on the pharmacokinetics of the dipeptidyl peptidase IV (DPP-4) inhibitor vildagliptin (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17486328%20AND%20SRC:MED&resulttype=core&format=json

30 December 2019

1 reference

Y-L He

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17486328%20AND%20SRC:MED&resulttype=core&format=json

30 December 2019

R Sabo

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17486328%20AND%20SRC:MED&resulttype=core&format=json

30 December 2019

J Campestrini

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17486328%20AND%20SRC:MED&resulttype=core&format=json

30 December 2019

Y Wang

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17486328%20AND%20SRC:MED&resulttype=core&format=json

30 December 2019

M Ligueros-Saylan

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17486328%20AND%20SRC:MED&resulttype=core&format=json

30 December 2019

K C Lasseter

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17486328%20AND%20SRC:MED&resulttype=core&format=json

30 December 2019

S C Dilzer

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17486328%20AND%20SRC:MED&resulttype=core&format=json

30 December 2019

D Howard

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17486328%20AND%20SRC:MED&resulttype=core&format=json

30 December 2019

W P Dole

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17486328%20AND%20SRC:MED&resulttype=core&format=json

30 December 2019

publication date

8 May 2007

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17486328%20AND%20SRC:MED&resulttype=core&format=json

European Journal of Clinical Pharmacology

30 December 2019

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17486328%20AND%20SRC:MED&resulttype=core&format=json

30 December 2019

volume

63

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17486328%20AND%20SRC:MED&resulttype=core&format=json

30 December 2019

issue

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17486328%20AND%20SRC:MED&resulttype=core&format=json

30 December 2019

page(s)

677-686

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17486328%20AND%20SRC:MED&resulttype=core&format=json

https://scigraph.springernature.com/pub.10.1007/s00228-007-0312-6

30 December 2019

exact match

0 references

cites work

Glucose intolerance but normal satiety in mice with a null mutation in the glucagon-like peptide 1 receptor gene.

1 reference

12 December 2020

Cimetidine administration and tubular creatinine secretion in patients with compensated cirrhosis

1 reference

12 December 2020

Glucose intolerance caused by a defect in the entero-insular axis: a study in gastric inhibitory polypeptide receptor knockout mice

1 reference

12 December 2020

Effects of liver disease on pharmacokinetics. An update

1 reference

12 December 2020

Differentiating members of the thiazolidinedione class: a focus on safety

1 reference

12 December 2020

Dipeptidyl peptidase IV inhibitors: a promising new therapeutic approach for the management of type 2 diabetes

1 reference

12 December 2020

Degradation of glucagon-like peptide-1 by human plasma in vitro yields an N-terminally truncated peptide that is a major endogenous metabolite in vivo

1 reference

12 December 2020

Glucagon-like peptide-1 (GLP-1): a gut hormone of potential interest in the treatment of diabetes

1 reference

12 December 2020

Transection of the oesophagus for bleeding oesophageal varices

1 reference

12 December 2020

Reduced postprandial concentrations of intact biologically active glucagon-like peptide 1 in type 2 diabetic patients.

1 reference

12 December 2020

Hepatic disease and drug pharmacokinetics

1 reference

12 December 2020

Responses and molecular heterogeneity of IR-GIP after intraduodenal glucose and fat.

1 reference

12 December 2020

Clinical pharmacokinetics in patients with liver disease

1 reference

12 December 2020

Rosiglitazone: a review of its use in the management of type 2 diabetes mellitus

1 reference

12 December 2020

Reduced incretin effect in type 2 (non-insulin-dependent) diabetes

1 reference

12 December 2020

Vildagliptin, a dipeptidyl peptidase-IV inhibitor, improves model-assessed beta-cell function in patients with type 2 diabetes

1 reference

12 December 2020

Twelve- and 52-week efficacy of the dipeptidyl peptidase IV inhibitor LAF237 in metformin-treated patients with type 2 diabetes

1 reference

12 December 2020

Therapy of type 2 diabetes mellitus based on the actions of glucagon-like peptide-1.

1 reference

12 December 2020

Single-dose pharmacokinetics of repaglinide in subjects with chronic liver disease.

1 reference

12 December 2020

Limitations of serum creatinine level and creatinine clearance as filtration markers in cirrhosis

1 reference

12 December 2020

Clinical pharmacokinetic and pharmacodynamic considerations in patients with liver disease. An update

1 reference

12 December 2020

Inhibition of dipeptidyl peptidase-4 reduces glycemia, sustains insulin levels, and reduces glucagon levels in type 2 diabetes

1 reference

12 December 2020